Dual variable domain immunoglobulins and uses thereof
Disclosed is a binding protein comprising first and second polypeptide chains, each independently comprising - VD1-(X1)n-VD2-C-(X2)n, wherein - VD1 is a first variable domain; - VD2 is a second variable domain; - C is a constant domain; - X1 is a linker; - X2 is an Fc region; - n is 0 or 1; - wherei...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | HARRIS MARIA C GU JIJIE MCPHERSON MICHAEL J ISAKSON PETER C SALFELD JOCHEN G LIU JUNJIAN GHAYUR TARIQ |
description | Disclosed is a binding protein comprising first and second polypeptide chains, each independently comprising - VD1-(X1)n-VD2-C-(X2)n, wherein - VD1 is a first variable domain; - VD2 is a second variable domain; - C is a constant domain; - X1 is a linker; - X2 is an Fc region; - n is 0 or 1; - wherein the VD1 domains on the first and second polypeptide chains form a first functional target binding site and the VD2 domains on the first and second polypeptide chains form a second functional target binding site, and wherein the binding protein is capable of binding TNF, wherein the variable domains that form a functional target binding site for TNF comprise CDRs 1-3 from SEQ ID NO: 40 and CDRs 1-3 from SEQ ID NO: 41, wherein SEQ ID NOs: 40 and 41 are disclosed within the specification. Also disclosed is the use of the above-described binding protein in the manufacture of a medicament for treating a subject for a disease or a disorder. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ620267A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ620267A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ620267A3</originalsourceid><addsrcrecordid>eNrjZDB1KU3MUShLLMpMTMpJVUjJz03MzFPIzM0tzctPz8lPKs3JzCtWSMxLUSgtTi1WKMlILUrNT-NhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfF-UWZGBkZm5o7GBBUAAH2CLFo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Dual variable domain immunoglobulins and uses thereof</title><source>esp@cenet</source><creator>HARRIS MARIA C ; GU JIJIE ; MCPHERSON MICHAEL J ; ISAKSON PETER C ; SALFELD JOCHEN G ; LIU JUNJIAN ; GHAYUR TARIQ</creator><creatorcontrib>HARRIS MARIA C ; GU JIJIE ; MCPHERSON MICHAEL J ; ISAKSON PETER C ; SALFELD JOCHEN G ; LIU JUNJIAN ; GHAYUR TARIQ</creatorcontrib><description>Disclosed is a binding protein comprising first and second polypeptide chains, each independently comprising - VD1-(X1)n-VD2-C-(X2)n, wherein - VD1 is a first variable domain; - VD2 is a second variable domain; - C is a constant domain; - X1 is a linker; - X2 is an Fc region; - n is 0 or 1; - wherein the VD1 domains on the first and second polypeptide chains form a first functional target binding site and the VD2 domains on the first and second polypeptide chains form a second functional target binding site, and wherein the binding protein is capable of binding TNF, wherein the variable domains that form a functional target binding site for TNF comprise CDRs 1-3 from SEQ ID NO: 40 and CDRs 1-3 from SEQ ID NO: 41, wherein SEQ ID NOs: 40 and 41 are disclosed within the specification. Also disclosed is the use of the above-described binding protein in the manufacture of a medicament for treating a subject for a disease or a disorder.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150626&DB=EPODOC&CC=NZ&NR=620267A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150626&DB=EPODOC&CC=NZ&NR=620267A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HARRIS MARIA C</creatorcontrib><creatorcontrib>GU JIJIE</creatorcontrib><creatorcontrib>MCPHERSON MICHAEL J</creatorcontrib><creatorcontrib>ISAKSON PETER C</creatorcontrib><creatorcontrib>SALFELD JOCHEN G</creatorcontrib><creatorcontrib>LIU JUNJIAN</creatorcontrib><creatorcontrib>GHAYUR TARIQ</creatorcontrib><title>Dual variable domain immunoglobulins and uses thereof</title><description>Disclosed is a binding protein comprising first and second polypeptide chains, each independently comprising - VD1-(X1)n-VD2-C-(X2)n, wherein - VD1 is a first variable domain; - VD2 is a second variable domain; - C is a constant domain; - X1 is a linker; - X2 is an Fc region; - n is 0 or 1; - wherein the VD1 domains on the first and second polypeptide chains form a first functional target binding site and the VD2 domains on the first and second polypeptide chains form a second functional target binding site, and wherein the binding protein is capable of binding TNF, wherein the variable domains that form a functional target binding site for TNF comprise CDRs 1-3 from SEQ ID NO: 40 and CDRs 1-3 from SEQ ID NO: 41, wherein SEQ ID NOs: 40 and 41 are disclosed within the specification. Also disclosed is the use of the above-described binding protein in the manufacture of a medicament for treating a subject for a disease or a disorder.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB1KU3MUShLLMpMTMpJVUjJz03MzFPIzM0tzctPz8lPKs3JzCtWSMxLUSgtTi1WKMlILUrNT-NhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfF-UWZGBkZm5o7GBBUAAH2CLFo</recordid><startdate>20150626</startdate><enddate>20150626</enddate><creator>HARRIS MARIA C</creator><creator>GU JIJIE</creator><creator>MCPHERSON MICHAEL J</creator><creator>ISAKSON PETER C</creator><creator>SALFELD JOCHEN G</creator><creator>LIU JUNJIAN</creator><creator>GHAYUR TARIQ</creator><scope>EVB</scope></search><sort><creationdate>20150626</creationdate><title>Dual variable domain immunoglobulins and uses thereof</title><author>HARRIS MARIA C ; GU JIJIE ; MCPHERSON MICHAEL J ; ISAKSON PETER C ; SALFELD JOCHEN G ; LIU JUNJIAN ; GHAYUR TARIQ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ620267A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>HARRIS MARIA C</creatorcontrib><creatorcontrib>GU JIJIE</creatorcontrib><creatorcontrib>MCPHERSON MICHAEL J</creatorcontrib><creatorcontrib>ISAKSON PETER C</creatorcontrib><creatorcontrib>SALFELD JOCHEN G</creatorcontrib><creatorcontrib>LIU JUNJIAN</creatorcontrib><creatorcontrib>GHAYUR TARIQ</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HARRIS MARIA C</au><au>GU JIJIE</au><au>MCPHERSON MICHAEL J</au><au>ISAKSON PETER C</au><au>SALFELD JOCHEN G</au><au>LIU JUNJIAN</au><au>GHAYUR TARIQ</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Dual variable domain immunoglobulins and uses thereof</title><date>2015-06-26</date><risdate>2015</risdate><abstract>Disclosed is a binding protein comprising first and second polypeptide chains, each independently comprising - VD1-(X1)n-VD2-C-(X2)n, wherein - VD1 is a first variable domain; - VD2 is a second variable domain; - C is a constant domain; - X1 is a linker; - X2 is an Fc region; - n is 0 or 1; - wherein the VD1 domains on the first and second polypeptide chains form a first functional target binding site and the VD2 domains on the first and second polypeptide chains form a second functional target binding site, and wherein the binding protein is capable of binding TNF, wherein the variable domains that form a functional target binding site for TNF comprise CDRs 1-3 from SEQ ID NO: 40 and CDRs 1-3 from SEQ ID NO: 41, wherein SEQ ID NOs: 40 and 41 are disclosed within the specification. Also disclosed is the use of the above-described binding protein in the manufacture of a medicament for treating a subject for a disease or a disorder.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_NZ620267A |
source | esp@cenet |
subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Dual variable domain immunoglobulins and uses thereof |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T05%3A41%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HARRIS%20MARIA%20C&rft.date=2015-06-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ620267A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |